Patient who received 6 doses of COVID-19 vaccine reports no adverse reaction

Amy Baxter | | Health Exec | COVID-19
Covid Vaccine

A patient who was given five times the regular dose of a COVID-19 vaccine by a distracted nurse has reported no adverse symptoms after being monitored at a hospital, CBS News reported.

The incident, which happened in Rome, occurred on Sunday, May 9. The patient was kept under observation for roughly 24 hours in the emergency room of Noa Hospital in Massa, Tuscany, where the vaccine was distributed. While doctors gave the affected woman fluids and anti-inflammatory and fever medications as preventative measures, no such fever appeared, and she was sent home.

"This person at this time will certainly not have side effects," Antonella Vicenti, director of infectious diseases at Noa Hospital, told CBS News.

Other studies on the Pfizer Covid-19 vaccine have revealed no adverse effects for patients receiving up to five times the normal dosage. However, it’s unknown what the long-term effect of the high dosage on antibodies for the woman. The hospital has since launched an investigation into its safety practices. 

See the full story below:

 

Distracted nurse gives woman 6 doses of COVID vaccine in a single shot

Amy Baxter
Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Related Content

Monitoring acute heart patients at home linked to considerable cost savings
Brazen marital healthcare scheme ends with guilty pleas
CityMD agrees to $12M settlement over alleged COVID claims fraud
Q&A: Cardiologist Karen Joynt Maddox on why new healthcare policies are not improving outcomes
Does Covid-19 raise risk for cancers—including rare ones?
FDA panel recommends new COVID-19 booster

Around the web

Cardiovascular Business
Q&A: Why are cardiovascular devices involved in so many recalls? FDA policies may be to blame

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Cardiovascular Business
Cardiologist compensation still rising, especially in invasive and interventional cardiology

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

Cardiovascular Business
FDA’s tirzepatide decision creates uncertainty for patients—and leads to a lawsuit

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Design by Adaptive Theme
Trimed Popup
Trimed Popup